chr9-136505383-AG-A
Variant names: 
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_017617.5(NOTCH1):c.4512delC(p.Cys1505ValfsTer75) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
 Genomes: not found (cov: 33) 
Consequence
 NOTCH1
NM_017617.5 frameshift
NM_017617.5 frameshift
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  3.15  
Publications
1 publications found 
Genes affected
 NOTCH1  (HGNC:7881):  (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016] 
NOTCH1 Gene-Disease associations (from GenCC):
- Adams-Oliver syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
 - Adams-Oliver syndrome 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
 - aortic valve disease 1Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia
 - connective tissue disorderInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - leukodystrophyInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - familial bicuspid aortic valveInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease. 
PM2
Very rare variant in population databases, with high coverage; 
PP5
Variant 9-136505383-AG-A is Pathogenic according to our data. Variant chr9-136505383-AG-A is described in ClinVar as Pathogenic. ClinVar VariationId is 12477.Status of the report is no_assertion_criteria_provided, 0 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD3 genomes 
Cov.: 
33
GnomAD4 exome Cov.: 33 
GnomAD4 exome 
Cov.: 
33
GnomAD4 genome  Cov.: 33 
GnomAD4 genome 
Cov.: 
33
ClinVar
Significance: Pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Aortic valve disease 1    Pathogenic:1 
Sep 08, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.